These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 15059354)
21. [Expression of melanoma antigen-1, 3 genes in human intrahepatic cholangiocarcinoma and its clinical significance]. Lu X; Zhao HT; Sang XT; Mao YL; Chen RR; Zhong SX; Huang JF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):197-200. PubMed ID: 18505125 [TBL] [Abstract][Full Text] [Related]
22. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152 [TBL] [Abstract][Full Text] [Related]
23. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof]. Shen HW; Wu YL; Peng SY Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749 [TBL] [Abstract][Full Text] [Related]
24. Expression of MAGE-A1 and MAGE-A3 genes in human salivary gland carcinomas. Liu J; Wang G; Okutomi T; Chen Z Chin Med J (Engl); 2003 Jun; 116(6):897-900. PubMed ID: 12877803 [TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
26. Expression of cancer-testis antigens in hepatocellular carcinoma. Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429 [TBL] [Abstract][Full Text] [Related]
27. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
28. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation]. Zhu B; Cong W; Wang H Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):217-20. PubMed ID: 10715791 [TBL] [Abstract][Full Text] [Related]
29. High frequency of the MAGE-1 gene expression in hepatocellular carcinoma. Yamashita N; Ishibashi H; Hayashida K; Kudo J; Takenaka K; Itoh K; Niho Y Hepatology; 1996 Dec; 24(6):1437-40. PubMed ID: 8938177 [TBL] [Abstract][Full Text] [Related]
30. mRNA expression of MAGE-A3 gene in leukemia cells. Martínez A; Olarte I; Mergold MA; Gutiérrez M; Rozen E; Collazo J; Amancio-Chassin O; Ordóñez RM; Montesinos JJ; Mayani H; McCurdy DK; Ostrosky-Wegman P; Garrido-Guerrero E; Miranda EI Leuk Res; 2007 Jan; 31(1):33-7. PubMed ID: 16806467 [TBL] [Abstract][Full Text] [Related]
31. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers. Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128 [TBL] [Abstract][Full Text] [Related]
33. Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma. Kariyama K; Higashi T; Kobayashi Y; Nouso K; Nakatsukasa H; Yamano T; Ishizaki M; Kaneyoshi T; Toshikuni N; Ohnishi T; Fujiwara K; Nakayama E; Terracciano L; Spagnoli GC; Tsuji T Br J Cancer; 1999 Nov; 81(6):1080-7. PubMed ID: 10576668 [TBL] [Abstract][Full Text] [Related]
34. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Qiu G; Fang J; He Y Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880 [TBL] [Abstract][Full Text] [Related]
35. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Miyasaka Y; Enomoto N; Nagayama K; Izumi N; Marumo F; Watanabe M; Sato C Br J Cancer; 2001 Jul; 85(2):228-34. PubMed ID: 11461082 [TBL] [Abstract][Full Text] [Related]
36. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma. Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452 [TBL] [Abstract][Full Text] [Related]
37. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China. Dong-Dong L; Xi-Ran Z Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194 [TBL] [Abstract][Full Text] [Related]
38. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence]. Yang SZ; Dong JH; Zhu J; Li K; Zhang Y Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354 [TBL] [Abstract][Full Text] [Related]
39. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
40. Expression of the midkine gene in human hepatocellular carcinomas. Koide N; Hada H; Shinji T; Ujike K; Hirasaki S; Yumoto Y; Hanafusa T; Kadomatsu K; Muramatsu H; Muramatsu T; Tsuji T Hepatogastroenterology; 1999; 46(30):3189-96. PubMed ID: 10626184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]